Clinical & translational oncology

• 

  Año 2021, Vol. 23, Número 8

  • Review Article

    • Complex roles of discoidin domain receptor tyrosine kinases in cancer

      V. Mehta, A. Munshi, H. Chander

      • Resumen

      págs. 1497-1510

      

    • Dosage of anti-PD-1 monoclonal antibodies: a cardinal open question

      Manuel Sureda González, E. Calvo, J.J. Mata, V. Escudero Ortiz, Elena María Martínez Navarro, Arantxa Catalán Ramos, Joseba Rebollo Liceaga

      • Resumen

      págs. 1511-1519

      

    • Patient profles as an aim to optimize selection in the second line setting: the role of afibercept

      Beatriz González Astorga, F. Salvà Ballabrera, Enrique Aranda Aguilar, Elena Élez Fernández, Pilar García Alfonso, E. González Flores, Ruth Vera García, Ana Fernández Montes, Ana María López Muñoz, Antonieta Salud

      • Resumen

      págs. 1520-1528

      

  • Special Article

    • Multidisciplinary consensus on optimising the detection of NTRK gene alterations in tumours

      Pilar Garrido López, R. Hladun, Enrique de Alava, R. Álvarez Álvarez, F. J. Bautista Sirvent, Fernando López-Rios Moreno, Ramón Colomer Bosch, F. Rojo

      • Resumen

      págs. 1529-1541

      

  • Research Article

    • CIP2A silencing alleviates doxorubicin resistance in MCF7/ADR cells through activating PP2A and autophagy

      Z. Zhu, Z. Wei

      • Resumen

      págs. 1542-1548

      

    • Preparation of a novel EGFR specifc immunotoxin and its efcacy of anti‑colorectal cancer in vitro and in vivo

      Shuifa Wu, Cuimin Deng, Caiyun Zhang, Jiani Xiong, Xiaofan Gu, Ze Wang, Jingjing Tu, Jieming Xie

      • Resumen

      págs. 1549-1560

      

    • Long‑term disease outcome and volume‑based decision strategy in a large cohort of multiple brain metastases treated with a mono‑isocentric linac‑based Stereotactic Radiosurgery technique

      F. Cuccia, R. Mazzola, F. Ricchetti, M. Rigo, C. Vitale, A. De Simone, S. Naccarato, G. Sicignano, D. Gurrera, S. Corradini, R. Ruggeri

      • Resumen

      págs. 1561-1570

      

    • Prognostic value of 18F‑FDG PET/CT in T‑Lymphoblastic lymphoma before and after hematopoietic stem cell transplantation

      N. Sun, W. Qiao, Y. Xing, T. Wang, J. Yang, J. Zhao

      • Resumen

      págs. 1571-1576

      

    • Stereotactic ablative radiotherapy in castration‑resistant prostate cancer patients with oligoprogression during androgen receptor‑targeted therapy

      G. Ingrosso, B. Detti, A. Fodor, S. Caini, S. Borghesi, L. Triggiani, F. Trippa, D. Russo, A. Bruni, G. Francolini, A. Lancia, L. Marinelli, N. Di Muzio, L. Livi, S. M. Magrini, Ernesto Maranzano, D. Musio, C. Aristei, M. Valeriani

      • Resumen

      págs. 1577-1584

      

    • Is lung resection appropriate for late octogenarians? Surgical outcomes of patients aged≥80 years with lung cancer

      Y. Iijima, S. Iwai, Akira Yamagata, N. Motono, K. Usuda, S. Yamagishi, K. Koizumi, H. Uramoto

      • Resumen

      págs. 1585-1592

      

    • Chronic toxicity and long‑term outcome in intraoperative electron radiotherapy as boost followed by whole‑breast irradiation

      G. Oses, C. Cases, Izaskun Valduvieco Ruiz, B. Farrús, I . Alonso, X. Caparrós, J. Mases, D. Muñoz Guglielmetti, Alberto Biete Solà, C. Castro, E. Escudero, M. Molina, Antonio Herreros, J. Saez, M. Mollà

      • Resumen

      págs. 1593-1600

      

    • Distribution of tumor‑infltrating‑T‑lymphocytes and possible tumor‑escape mechanisms avoiding immune cell attack in locally advanced adenocarcinomas of the esophagus

      M. Schoemmel, H. Loeser, M. Kraemer, S. Wagener Ryczek, A. Hillmer, C. Bruns, M. Thelen, W. Schröder, T. Zander, R. Buettner

      • Resumen

      págs. 1601-1610

      

    • The role of brachytherapy (interventional radiotherapy) for primary and/or recurrent vulvar cancer: a Gemelli Vul.Can multidisciplinary team systematic review

      V. Lancellotta, G. Macchia, G. Garganese, B. Fionda, C. Casà, M. Fragomeni, B. Gui, S. Gentileschi

      • Resumen

      págs. 1611-1619

      

    • Associations of PD‑L1, PD‑L2, and HLA class I expression with responses to immunotherapy in patients with advanced sarcoma: post hoc analysis of a phase 1/2 trial

      S. Miwa, T. Nojima, A.A. Alomesen, H. Ikeda, N. Yamamoto, H. Nishida, H. Hayashi, E. Takeuchi, Kumiko Igarashi, Toru Higuchi, H. Yonezawa, Y. Araki, S. Morinaga, Y. Asano, H. Tsuchiya

      • Resumen

      págs. 1620-1629

      

    • PILE:: a candidate prognostic score in cancer patients treated with immunotherapy

      D.C. Guven, H.C. Yildirim, E. Bilgin, T.K. Sahin, I.Y Cakir, S. Akin, O. Dizdar, S. Aksoy, S. Yalcin, M. Erman, S. Kilickap

      págs. 1630-1636

      

    • UCHL3 promotes aerobic glycolysis of pancreatic cancer through upregulating LDHA expression

      Y. Fan, D. Hu, D. Li, C. Ma, Y. Tang, Q. Tao, L. Deng, D. Tang

      • Resumen

      págs. 1637-1645

      

    • Peripheral blood T‑cell receptor repertoire as a predictor of clinical outcomes in gastrointestinal cancer patients treated with PD‑1 inhibitor

      S. Ji, J. Li, L. Chang, C. Zhao, R. Jia, Z. Tan, R. Liu, Y. Zhang, Y. Li

      • Resumen

      págs. 1646-1656

      

    • Pattern of care in radiotherapy at a University Hospital in Spain: the RENORT project

      José López Torrecilla, Desamparados González Sanchís, D. Granero-Cabañero, E. García Miragall, Piedad Almendros Blanco, Ana Hernández Machancoses, Luis Brualla Gonzalez, Jorge Rafael Pastor Peidro, Jose Carlos Gordo Partearroyo, Joan Roselló Ferrando

      • Resumen

      págs. 1657-1665

      

    • Sequential chemotherapy regimen of induction with panitumumab and paclitaxel followed by radiotherapy and panitumumab in patients with locally advanced head and neck cancer unft for platinum derivatives. The phase II, PANTERA/TTCC‑2010‑06 study

      Javier Martínez Trufero, Alicia Lozano, Isabel Pajares Bernad, M. Taberna, Eugenia Ortega Izquierdo, Beatriz Cirauqui Cirauqui, J. Rubió Casadevall, M. Plana Serrahima, J.M. Ponce Ortega, Isabel Planas Toledano, Javier Caballero Daroqui, J. Marruecos, Lara Iglesias Docampo, Julio José Lambea Sorrosal, Juan Carlos Adansa Klain, Ricard Mesía Nin

      • Resumen

      págs. 1666-1677

      

    • Hypoxia‑mediated down‑regulation of miRNAs’ biogenesis promotes tumor immune escape in bladder cancer

      Y. Zhao, Z. Shi, Z. Hao, J. Zhou, C. Han, R. Li, Q. Lv, Y. Liu, C. Liang

      • Resumen

      págs. 1678-1687

      

    • A new antisarcoma strategy:: multisubtype heat shock protein/peptide immunotherapy combined with PD‑L1 immunological checkpoint inhibitors

      H. Li, Z. Wang, M. Yuan

      • Resumen

      págs. 1688-1704

      

    • α1 adrenergic receptors in serum and saliva of patients with oral squamous cell carcinoma

      Narges Gholizadeh, Amir Hossein Mohebbi, Iraj Mirzaii Dizgah, Nafseh Sheykhbahaei

      • Resumen

      págs. 1705-1710

      

    • Expression of bone morphogenetic protein 10 in cases with endometrial carcinoma and its clinical signifcance

      Y. Hu, L. Yu, D. Xia, F. Liang, C. Cheng, Y. Huang, L. Xiao

      • Resumen

      págs. 1711-1716

      

    • Oligo metastatic renal cell carcinoma: stereotactic body radiation therapy, if, when and how?

      G. Marvaso, G. Corrao, O. Oneta, M. Pepa, M. Zaffaroni, O. de Cobelli, Roberto Orecchia, Barbara A. Jereczek-Fossa

      • Resumen

      págs. 1717-1726

      

    • Letter to the editor

      Kita Sallabanda, Luis Ley Urzáiz

      págs. 1727-1728

      

  • Correspondence

    • the editor

      Kita Sallabanda, Luis Ley Urzáiz

      págs. 1727-1728

      

    • To the editor, response letter

      Antonio José Conde Moreno, D. Zucca Aparicio, José Pérez Calatayud, F. López Campos, Francisco Javier Celada Álvarez, C. Rubio, Pedro Fernández Letón, Antonio Gómez Caamaño, D. Guirado, Jorge Contreras Martínez

      págs. 1729-1730